Paid Clinical Trials in Dallas, TX

As of September 2026, 1,555 paid clinical trials are recruiting in Dallas, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 4, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,370 clinical trials

Get a weekly email when new trials open in Dallas, TX.

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

for Non Hodgkin Lymphoma

Sites in Dallas +10 more locations

Sponsor: Miltenyi Biomedicine GmbH

Sex: All·Age: 18+

Code: NCT06116110·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

for Niemann-Pick Type C Disease

Sites in Dallas +4 more locations

Sponsor: Azafaros B.V.

Sex: All·Age: 4+

Code: NCT07082725·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

for Familial Partial Lipodystrophy

Sites in Dallas +6 more locations

Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All·Age: 13+

Code: NCT06679270·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

for Diffuse Astrocytoma, IDH-Mutant

Sites in Dallas +6 more locations

Sponsor: Neonc Technologies, Inc.

Sex: All·Age: 18+

Code: NCT06047379·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for Niemann-Pick Type C Disease

Sites in Dallas +4 more locations

Sponsor: Azafaros B.V.

Sex: All·Age: 4+

Code: NCT07054515·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

for Solid Malignancies

Sites in Dallas, San Antonio +1 more location

Sponsor: Carrick Therapeutics Limited

Sex: All·Age: 18+

Code: NCT06600789·Phase 1, Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

NEO100 and High-Grade Meningioma

for Residual, Progressive or Recurrent Grade II or III Meningioma

Sites in Dallas +4 more locations

Sponsor: Neonc Technologies, Inc.

Sex: All·Age: 12+

Code: NCT05023018·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

for X-linked Retinoschisis

Sites in Dallas +17 more locations

Sponsor: Atsena Therapeutics Inc.

Sex: All·Age: 6+

Code: NCT05878860·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

for Kidney Diseases

Sites in Dallas, Houston +7 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT06858319·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Infant Formula in Infants and Children With Cow's Milk Allergy

for Cow's Milk Allergy

Sites in Dallas +7 more locations

Sponsor: Abbott Nutrition

Sex: All·Age: 3 Months - 12

Code: NCT06456541·Recruiting·Listed Jun 2024

Apply to this trial

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for Solid Tumor Malignancies

Sites in Dallas, Houston +4 more locations

Sponsor: A2A Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT06136884·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

for Hormone Receptor-positive Breast Cancer

Sites in Dallas +5 more locations

Sponsor: Ellipses Pharma

Sex: Female·Age: 18+

Code: NCT05573126·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

for Cancer

Sites in Dallas, Richardson +4 more locations

Sponsor: Helio Genomics

Sex: All·Age: 18+

Code: NCT05181826·Recruiting·Listed Jan 2022

Apply to this trial

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

for Coronary Artery Disease

Sites in Dallas, Kyle +8 more locations

Sponsor: Teleflex

Sex: All·Age: 18+

Code: NCT06779630·Recruiting·Listed Jan 2025

Apply to this trial

Asciminib Roll-over Study

for Chronic Myelogenous Leukemia

Sites in Dallas, Houston +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 7 - 100

Code: NCT04877522·Phase 4·Recruiting·Listed May 2021

Apply to this trial

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

for CLL / SLL

Sites in Dallas +4 more locations

Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All·Age: 18+

Code: NCT06708897·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

A Study of DM005 in Patients With Advanced Solid Tumors

for Carcinoma, Non-Small-Cell Lung

Sites in Dallas +2 more locations

Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd.

Sex: All·Age: 18+

Code: NCT06515990·Phase 1, Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

for Spasticity

Sites in Dallas +3 more locations

Sponsor: Ipsen

Sex: All·Age: 18 - 70

Code: NCT04752774·Phase 1, Phase 2·Recruiting·Listed Feb 2021

Apply to this trial

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

for Elevated Blood Pressure

Sites in Dallas, Houston +8 more locations

Sponsor: Zona Health, Inc

Sex: All·Age: 22+

Code: NCT06843577·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

for Multiple Myeloma

Sites in Dallas +13 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06892522·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Study of STP938 (Dencatistat) in Advanced Solid Tumours

for Solid Tumor

Sites in Dallas, San Antonio +1 more location

Sponsor: Step Pharma, SAS

Sex: All·Age: 18+

Code: NCT06297525·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

Radiation Free Study

for Aortic Aneurysm

Sites in Dallas +4 more locations

Sponsor: Philips Clinical & Medical Affairs Global

Sex: All·Age: 18+

Code: NCT06549348·Recruiting·Listed Aug 2024

Apply to this trial

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

for Cancer

Sites in Dallas +2 more locations

Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07317505·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)

for Spasticity, Muscle

1 location in Dallas

Sponsor: Elpida Therapeutics SPC

Sex: All·Age: 4 Months - 10

Code: NCT05518188·Phase 1, Phase 2·Recruiting·Listed Aug 2022

Apply to this trial

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for Melanoma

Sites in Dallas +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 6 Months - 17

Code: NCT02332668·Phase 1, Phase 2·Recruiting·Listed Jan 2015

Apply to this trial

A Study of Patients With Fabry Disease (US Specific)

for Fabry Disease

Sites in Dallas +7 more locations

Sponsor: Amicus Therapeutics

Sex: All·Age: 18+

Code: NCT06906367·Recruiting·Listed Apr 2025

Apply to this trial

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for Breast Neoplasms

Sites in Dallas, Houston +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06797635·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

for Hepatocellular Carcinoma

Sites in Dallas +4 more locations

Sponsor: Eureka Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT04864054·Phase 1, Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

SPI-1005 in Adults Receiving Cochlear Implant

for Hearing Loss

Sites in Dallas +5 more locations

Sponsor: Sound Pharmaceuticals, Incorporated

Sex: All·Age: 18+

Code: NCT06340633·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Falcon Real World Evidence Registry

for Cancer

Sites in Dallas +1 more location

Sponsor: Exact Sciences Corporation

Sex: All·Age: 50 - 80·Accepts healthy volunteers

Code: NCT06589310·Recruiting·Listed Sep 2024

Apply to this trial

US Post-Market Surveillance Study of the Surfacer System

for Venous Disease

Sites in Dallas, Houston +5 more locations

Sponsor: Merit Medical Systems, Inc.

Sex: All·Age: 18+

Code: NCT05050799·Recruiting·Listed Sep 2021

Apply to this trial

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

for Multiple Sclerosis

Sites in Dallas, Plano +4 more locations

Sponsor: ModernaTX, Inc.

Sex: All·Age: 18 - 55

Code: NCT06735248·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

for Solid Tumors, Adult

1 location in Dallas

Sponsor: HighField Biopharmaceuticals Corporation

Sex: All·Age: 18 - 75

Code: NCT05861895·Phase 1·Recruiting·Listed May 2023

Apply to this trial

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

for Metastatic Breast Cancer in the Liver

Sites in Dallas +3 more locations

Sponsor: Delcath Systems Inc.

Sex: All·Age: 18+

Code: NCT06875128·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

for End Stage Renal Disease

Sites in Dallas, Houston +5 more locations

Sponsor: Merit Medical Systems, Inc.

Sex: All·Age: 18+

Code: NCT06422871·Recruiting·Listed May 2024

Apply to this trial

Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma

for Advanced Unresectable Hepatocellular Carcinoma

Drug: Tremelimumab

Sites in Dallas, Fort Worth +2 more locations

Sponsor: Riboscience, LLC.

Sex: All·Age: 18+

Code: NCT07175441·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Long-Term Study of JNT-517 in Participants With Phenylketonuria

for Phenylketonuria (PKU)

Sites in Dallas, Houston +6 more locations

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All·Age: 4+

Code: NCT06628128·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

for ARB

Sites in Dallas +3 more locations

Sponsor: Opus Genetics, Inc

Sex: All·Age: 18+

Code: NCT07185256·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

for Adenocarcinoma of Lung

Sites in Dallas +4 more locations

Sponsor: Lantern Pharma Inc.

Sex: All·Age: 18+

Code: NCT05456256·Phase 2·Recruiting·Listed Jul 2022

Apply to this trial

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for B-cell Non-Hodgkins Lymphoma (B-NHL)

Drug: Odronextamab

Sites in Dallas +8 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05685173·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial